Aiming to reduce the burden of cardiovascular disease – the number one cause of mortality in western society.

Sydney Cardiovascular Research Consortium

Sydney CRC

The Sydney Cardiovascular Research Consortium (Sydney CRC) is the largest partnership of cardiovascular researchers in Australia, bringing together enormous resources and expertise in a unified and focused collaboration.

“The overarching vision of the Sydney CRC is to find entirely new and innovative approaches to dramatically reduce the burden of cardiovascular disease on the community.” – Professor Shaun Jackson.

Sydney CRC is comprised of Heart Research Institute (HRI), The University of Sydney (USYD), Charles Perkins Centre (CPC), Royal Prince Alfred Hospital (RPA), Sydney Local Health District (SLHD), and affiliated medical research institutes such as the Centenary Institute and The George Institute for Global Health.


The Heart Research Institute and the Charles Perkins Centre of the University of Sydney are seeking exceptional national and international early to mid-career researchers with the potential to become global leaders in cardiovascular research for the Sydney Cardiovascular Fellowships.

These fellowships represent the most prestigious fellowships in Australia for cardiovascular researchers and are valued at $1,000,000 over a period of five years. The fellowships are open to Australian and international applicants.



The Consortium is thrilled to announce partnership with Sydney Imaging and is offering a five-year fellowship worth $1,000,000 within the School of Biomedical Engineering, Faculty of Engineering and Information Technologies.  

Professor Fernando Calamante – PhD BSc

Director of School of Biomedical Engineering, Faculty of Engineering and Information Technologies

Sydney Imaging (

Sydney Imaging is a new Core Research Facility at the University, and one of the platforms for collaboration that provides access to state-of-the-art research infrastructure and services. It was designed to advance our fundamental understanding of biomedical science, as well as to promote bench-to-bedside translation of new discoveries into clinical practice. It was founded on three key pillars: preclinical imaging (to facilitate research in models of disease), clinical imaging (to enable research imaging in patients), and the Hybrid Theatre (a unique facility combining biomedical imaging, artificial intelligence, robotics and pioneering surgical practice).

Faculty of Engineering and Information Technologies (

The Faculty of Engineering and Information technologies is the fourth largest of The University of Sydney’s faculties and ranked among the top 50 engineering and technology universities in the world. Research undertaken within the Faculty is multidisciplinary and centred on the key themes of: field robotics, agricultural robotics, biomedical engineering and technologies, human-centred technology, complex systems, materials and structures, food processing, clean, and intelligent energy networks. These research themes break down conventional disciplinary barriers and enable us to work collaboratively to develop truly holistic solutions to today’s big issues.


In 2018, the NSW Government established the Cardiovascular Disease Research Capacity Building Program: a $150 million funding package to support the state’s current world-renowned cardiovascular researchers and future NSW-based researchers.

This innovative program will focus on fast tracking new treatments and prevention strategies, and confirms NSW – the home of Sydney CRC – as the premier state for cardiovascular health in Australia.


Press release


To achieve our mission of dramatically reducing the burden of cardiovascular disease, the Sydney CRC has developed a powerful research pipeline that optimises opportunity for discovery of novel markers, effectors, and predictors of cardiovascular disease, mechanistic interrogation in the laboratory, and the subsequent implementation of findings into clinical practice.

By harnessing well-phenotyped clinical cohorts, robust post-genomic profiling platforms, state-of-the-art laboratories, drug development and biomaterial engineering facilities, and world-renowned expertise in each of these disciplines, we are in a strong position to make significant advances in cardiovascular research.


Take a virtual tour of our world class facilities

Advantages of the Sydney CRC approach:

  • A much greater critical mass of cardiovascular research
  • A destination for the most competitive cardiovascular basic biomedical researchers
  • A number of world class research areas through new collaborations established between HRI and Charles Perkins Centre/USyd/SLHD/Sydney Research
  • A destination for world-class education and training

Core activities include:

  • A discovery engine
  • A focus on developing new and innovative therapeutics
  • More effective delivery of healthcare (the golden hour)
  • Development of new coatings and materials (stents, valves, artificial blood vessels etc)
  • Advances in robotics and minimally invasive CV surgery.
  • Post-genomic and metabolomics research.


We welcome the newest members of the Sydney Cardiovascular Research Consortium, each exploring groundbreaking research into different areas and aspects of cardiovascular disease.

Dr John O’Sullivan – MD PhD FAHA FRCPI

Cardiometabolic Disease Group Leader, Heart Research Institute & The University of Sydney

Read more about Dr O’Sullivan

Dr Anna Waterhouse – PhD BSc (Hons I)

Cardiovascular Medical Devices Group Leader, Heart Research Institute & The University of Sydney

Read more about Dr Waterhouse

Dr Ashish Misra – BSc M.Tech PhD

Atherosclerosis and Vascular Remodeling Group Leader, Heart Research Institute

Dr Freda Passam – MD PhD FRACP FRCPA

Haematology Research Group Leader, Heart Research Institute & The University of Sydney

Dr Xuyu Liu – PhD MSc BSc

Cardiovascular-protective Signalling and Drug Discovery Unit Leader


Our world-renowned investigators lead research spanning all facets of cardiovascular disease, with particular strength in biomedical and clinical research and trials. Key researchers include the following.


Professor Shaun Jackson – MBBS (Hons) BMedSci (Hons) PhD

Director of Cardiovascular Research, Heart Research Institute
Charles Perkins Centre

Professor David Celermajer – MBBS MSc PhD DSc FAHA FRACP FAA

Scandrett Professor of Cardiology, The Univeristy of Sydney
Medicine, Central Clinical School
Clinical Director, The Heart Research Institute

Professor Christopher Semsarian – MBBS PhD MPH FRACP FCSANZ FHRS FAHA

Professor of Medicine, Sydney Medical School
Cardiologist, Royal Prince Alfred Hospital, Central Clinical School
Head, Molecular Cardiology Program, Centenary Institute

Professor Stephen Simpson AC BSc MA PhD FAA FRS

Academic Director, Charles Perkins Centre
Professor, School of Life and Environmental Sciences

Professor David James  – FAA

Leonard P. Ullmann Chair of Metabolic Systems Biology, Charles Perkins Centre
Professor, School of Life & Environmental Sciences and Sydney Medical School

Professor Philip Hogg  

Head, ACRF–Centenary Cancer Research Centre
Sydney Catalyst Chair in Translational Cancer Research

Other Opportunities

The Heart Research Institute is also pleased to announce the launch of the inaugural 2020 Robert Edward Gough Fellowship, with thanks to the extraordinary generosity of the late Robert Edward Gough.

This innovative fellowship scheme, valued at $1,000,000 over a period of five years ($200,000/yr), has been developed to support early-career researchers in the field of cardiovascular science and medicine.

Visit the Robert Edward Gough Fellowship page to find out more.


Find Out More


Submit an enquiry

If you have a question about the Sydney Cardiovascular Fellowships, please submit your enquiry through the form on the right, and we will contact you shortly.